Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery Can Help Eliminate Chronic Lymphedema

By HospiMedica International staff writers
Posted on 07 Dec 2015
Two different microsurgery techniques could help relieve the painful swelling caused by chronic lymphedema following cancer treatment.

The two procedures, lymphovenous bypass and vascularized lymph node transfer, involve rerouting lymphatic channels to allow for proper fluid drainage. More...
In the lymphovenous bypass procedure, lymphatic channels are rerouted into functioning veins so that lymphatic system blockages can be bypassed to allow fluids to be transported back to the heart via the venous system. The procedure can be performed on vessels less than one millimeter in diameter using supermicrosurgery techniques, which although technically challenging show promising results.

In the vascularized lymph node transfer (VLNTx) procedure, normal lymph nodes and the associated adipose tissues are transferred to a region of the body that suffers from lymphedema as a means to decrease limb size, alleviate subjective discomfort symptoms and early fatigue, potentially reduce daily compression requirements, and slow progression of the disease. Key aspects of the VLNTx approach include patient selection, a no-touch, atraumatic harvesting technique, aggressive adhesionolysis in the area of injury, and meticulous microsurgical technique.

“This is a huge clinical issue that has serious quality-of-life implications for cancers survivors; 40%–60% of all cancer patients who have full lymph node removal are at risk of developing lymphedema; in breast cancer specifically, up to 40% of survivors will develop the condition,” said Roman Skoracki, MD, division chief of oncologic plastic surgery at the Ohio State University (OSU; Columbus, USA) comprehensive cancer center. “This excess fluid can make a person’s limbs feel heavy and cause a physical as well as a psychological burden for the patient that is very troubling.”

“Now we can offer patients a surgical approach to better manage their lymphedema, and in some cases prevent it from occurring entirely,” added Dr. Skoracki. “After lymphedema-relieving surgery, more than 60% of patients will have a significant improvement in their symptoms. Additionally, in more than 50% of patients we are able to measure a very significant decrease in the size of their affected limb.”

Chronic lymphedema is most common in breast cancer patients, but can occur in all cancers that require full lymph node dissection to confirm the extent of disease and determine if chemotherapy or radiation treatments are necessary. If too many lymph fluid channels are removed, the fluid downstream becomes trapped, leading to the development of lymphedema. Traditionally, it has been managed with a combination of physical therapy and compression bandaging, but once the condition occurs it cannot be eliminated entirely.

Related Links:

Ohio State University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.